Ireland· IE-PA-PA1824/018/001
Relestat, 0.5 mg/ml, eye drops, solution
A epinastine product containing epinastine hydrochloride, registered in Ireland by AbbVie Limited. The same ATC class is registered in 8 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Epinastine is registered in 8 of 19 countries.
Countries holding a registration under ATC S01GX10 (epinastine), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 5 of them publish a price we can compare per daily dose
Epinastine · ATC S01GX10
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Ireland
- Netherlands
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
HPRA (Ireland)- Active substance
- Epinastine hydrochloride
- Manufacturer
- AbbVie Limited
- Country
- Ireland (IE)
- ATC code
- S01GX10
- ATC class
- Epinastine
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA1824/018/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Epinastine in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumRelestat 0.5 mg/mlAbbvie
- CzechiaPURIVISTAbbVie s.r.o., Praha
- FinlandRelestatAllergan Pharmaceuticals Ireland
- FrancePURIVIST 0,5 mg/ml, collyre en solutionABBVIE
- NetherlandsRelestat, oogdruppels, oplossing 0,5 mg/mlAbbVie B.V.
- PolandRelestatAbbVie Sp. z o.o.
- SwedenRelestat 0,5 mg/ml Ögondroppar, lösningAbbVie AB
- United StatesEPINASTINE HYDROCHLORIDESomerset Therapeutics, LLC
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Belgium · Relestat
- Czechia · Purivist
- France · Purivist
- United Kingdom (Northern Ireland) · Relestat
- Greece · Optallerg, Relestat
- Hungary · Relestat
- Italy · Relestat
- Luxembourg · Relestat
- Netherlands · Relestat
- Portugal · Relestat
- Sweden · Relestat
- Slovakia · Purivist
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/79ddce6d-4238-4d00-825b-2b92ebecee70 GET /v1/drugs/79ddce6d-4238-4d00-825b-2b92ebecee70?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Eye drops, solution",
"routes": [
"Ocular use"
],
"source": "hpra",
"atc_all": [
"S01GX",
"S01GX10"
],
"strength": null,
"pa_number": "PA1824/018/001",
"substances": [
"Epinastine hydrochloride"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Not marketed",
"authorised_at": "22/08/2003",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about epinastine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.